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Polychlorinated biphenyls (PCBs) belong to
a large group of halogenated aromatic hydro-
carbons and consist of 209 theoretically pos-
sible congeners with different numbers and
positions of chlorines (1,2). These com-
pounds were commercially produced as
Aroclor mixtures in the United States by the
chlorination of biphenyl, which produces
technical mixtures containing a given chlo-
rine content depending on the duration of
the chlorination process. Although all 209
congeners can be synthesized, the reaction
conditions in the commercial processes favor
certain substitution reactions leading to par-
ticular composition of the technical mix-
tures, which are identified by the weight
percentage of chlorine content. For example,
Aroclor 1254 contains 54% chlorine by
weight, as indicated by the last two digits in
the numeric designation (1–5). 
These compounds were used widely in
industry as heat transfer fluids, hydraulic
lubricants, dielectric fluids for transformers
and capacitors, ﬂame retardants, plasticizers,
and sealants and in carbonless copy paper
because of their chemical and thermal stabil-
ity, dielectric properties, and miscibility with
organic compounds. These same properties
have now contributed to their ability to cause
environmental and human health problems
(6–9). PCBs are distributed throughout the
entire ecosystem including soil, air, and water
(10). They are also highly likely to bioaccu-
mulate in the food chain because of their
lipophilicity, and they therefore belong to a
class of environmental chemicals called persis-
tent bioaccumulative toxicants (PBTs) (11).
PCBs have a wide range of effects in
humans, including chloracne, diverse
hepatic effects, decreased birth weight in the 
offspring of occupationally exposed mothers,
decreased pulmonary function, eye irritation,
subtle endocrine disturbances, cancer, and
learning and memory deficits (10–13).
Several of these effects have also been
demonstrated in animals during adult and
developmental exposure to commercial PCB
mixtures such as Aroclor 1254 (6,7,9,11,
14,15). In animal models, some individual
PCB congeners and commercial PCB mix-
tures have shown tumor-promoting activity
(16). The information from these animal
studies with commercial PCB mixtures has
been used in the risk/exposure assessment of
PCBs and related environmental chemicals
(2,15). However, recent reports using high-
resolution gas chromatography (HRGC)
indicate substantial differences in the con-
gener composition among Aroclor lots
(17,18); hence their biologic effects could be
different. Toxicity studies with Aroclor 1254
have produced varied results (19,20), but
these differences were attributed to the ani-
mal species or dosing paradigm rather than
to the composition of Aroclor 1254. We
designed the current study to study the
effects of two lots of Aroclor 1254 (lots 6024
and 124-191) obtained from AccuStandard
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Articles
Aroclor 1254 is a widely studied commercial polychlorinated biphenyl (PCB) mixture which, by
deﬁnition, contains 54% chlorine by weight. Recent reports indicate substantial differences in the
congener composition among Aroclor lots and hence their biologic effects. We designed the cur-
rent study to compare the effects of two lots of Aroclor 1254 (lots 6024 and 124-191). We ana-
lyzed these two lots for PCB congeners, polychlorinated dibenzofurans (PCDFs), polychlorinated
naphthalenes (PCNs), and polychlorinated dibenzodioxins (PCDDs). We used previously estab-
lished techniques for analyzing intracellular Ca2+ buffering and protein kinase C (PKC) transloca-
tion to test their biologic activity in neuronal preparations. PCB congener-specific analysis
indicated that ortho and non-ortho congeners in these two lots varied in their percent contribu-
tion. Among all congeners, the percentages of non-ortho congeners (PCBs 77, 81, 126, and 169)
were higher in lot 6024 (2.9% of total) than in lot 124-191 (0.02% of total). We detected no
dioxins in these two lots (< 2 ppb). Although there are some differences in the congener composi-
tion, total PCNs were similar in both lots: 171 ppm in lot 6024 and 155 ppm in lot 124-191.
However, total PCDFs were higher in lot 6024 (38.7 ppm) than in lot 124-191 (11.3 ppm).
When we tested these two Aroclors on Ca2+ buffering and PKC translocation in brain prepara-
tions, the effects were significantly different. Although lot 124-191 was more potent on PKC
translocation than lot 6024, lot 6024 was slightly more active on Ca2+ buffering than lot 124-
191. These effects could not be attributed to the differences in the percentage of non-ortho con-
geners or PCDFs because they were inactive on these two parameters. The effects could not be
attributed to PCNs because the levels were almost similar. The effects seen with two lots of
Aroclor 1254 in neuronal cells were also not predicted based on the TCDD toxic equivalents
(TEQs), although TEQs predicted the effects on ethoxyresorufin-O-deethylase (EROD) or
methoxyresoruﬁn-O-deethylase (MROD) activities. It is possible that the differential effects seen
in neuronal cells could be caused by differences in the composition of ortho-congeners in these
two mixtures, because PCBs with ortho-lateral substitutions can exhibit different activities on the
selected neurochemical end points. Because of these differential effects with different lot num-
bers, the composition of Aroclor mixtures used in investigations should be disclosed. Key words:
Aroclor 1254, dioxins, polychlorinated biphenyls, protein kinase C, toxic equivalents. Environ
Health Perspect 109:1153–1161 (2001). [Online 5 November 2001]
http://ehpnet1.niehs.nih.gov/docs/2001/109p1153-1161kodavanti/abstract.html(New Haven, CT, USA) on the neurochem-
ical end points that were previously reported
to be sensitive to PCBs in neuronal prepara-
tions (21–23) and to compare the effects
with the PCB congener composition and
other contaminants in these two lots of
Aroclor 1254. These two lots of Aroclor
1254 have been used widely by investigators
for the last several years.
Materials and Methods
Chemicals. Aroclor 1254 (> 99% purity)
with lot numbers 6024 and 124-191 were
purchased from AccuStandard. For neuro-
chemical experiments, we prepared stock
solutions of two Aroclor 1254 lots by dissolv-
ing them in dimethyl sulfoxide (DMSO). A
2-µL aliquot of stock solution (different con-
centrations) was added to the buffer to yield
the desired final concentrations. DMSO (2
µL/mL) had no significant effect either on
45Ca2+ uptake or 3H-phorbol ester binding. 
Animals. Timed pregnant female (13
days of gestation) and adult male (90–120
days) Long-Evans rats were obtained from
Charles River Laboratory. Pregnant dams
were housed individually and adult rats were
housed two per cage in Association for
Assessment and Accreditation of Laboratory
Animal Care-approved animal facilities.
Food (Rodent Chow; Purina, St. Louis,
MO) and water were provided ad libitum.
Temperature was maintained at 21 ± 2°C
and relative humidity at 50 ± 10% with a
12-hr light/dark cycle (0700–1900 hr).
PCB congener-speciﬁc analysis of two lots
of Aroclor 1254 with two lot numbers. We
performed congener-specific analysis of
PCBs according to previously established
method (24–26).
Non-ortho, coplanar PCBs must be iso-
lated from other dominant ortho-PCBs for
their trace level determination. This is
achieved by the use of Cosmosil 5-PYE col-
umn-HPLC method, as described in Kannan
et al. (26). HPLC was performed with
Pump-Constametric III with Rheodyne
injector (LDC Analytical Gmbh, GH
Friedrich, Germany) and the ﬂow rate was 1
mL of hexane per minute on Cosmosil 5-
PYE column [2-(1-pyrenyl) ethyldimethylsi-
lylated silica gel], 250 × 4.6 mm, particle size
5 mm (Nacalai Tesque, Kyoto, Japan). From
the stock solution (~1 ng/µL), 100 µL was
injected and the eluates were collected in 4
fractions of 16 mL. The dead volume was 3.5
mL. The ﬁrst fraction: 3.5–5.0 mL; second
fraction 5–7.5 mL; third fraction 7.5–16 mL.
These fractions were subsequently cooled
(0oC) and concentrated using vacuum ﬂash
evaporator (ﬂushing with N2) and analyzed
in high-resolution multidimensional gas
chromatography-electron capture detector
(HRMDGC-ECD). 
This was performed using Fison 8000
GC-ECD (Fison Instruments Gmbh,
Goettingen, Germany) with moving capil-
lary stream switching technique. The gas
chromatograph was equipped with a column
injector, two columns in two independent
ovens and two Ni63 electron capture detec-
tors. An apolar SE-54 (50 m length, 0.25
mm internal diameter) was placed in the ﬁrst
oven, and a more polar OV-210 (30 m
length, 0.32 mm internal diameter) in the
second one. Gas pressure (H2) was 1.1 bar
and 0.6 bar. Temperature programming
conditions were as follows: first column
from 50oC (1 min) to 160oC (5 min) up to
250oC at 5oC per min and the second col-
umn at 100oC until 20 min after injection;
then temperature increased to 240oC at 5oC
per min. The instrument was well tuned to
inject the sample three times and the average
was taken. Because non-ortho PCBs con-
tribute to many of the toxic equivalents
(TEQ) values, we extracted triplicate sam-
ples. The variability was always less than
10%. Standardization of this method was
done using artiﬁcially created PCB mixture
containing 46 individual congeners from
non-ortho to tetra-ortho chlorine substituted
PCBs (Table 1).
We determined coplanar PCBs exclu-
sively from the III fraction of PYE column
chromatography using individual PCBs 77,
81, 126, and 169 standards (99.9% pure).
Any possible coelution from other congeners
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Table 1. Composition of polychlorinated biphenyls in the standard solution, their structures, IUPAC numbers,
number of ortho-chlorine substitution, and the coeluting congeners. 
Concentration Coelution 
IUPAC no. Structure (pg/µL) Fraction No. of ortho Cl (IUPAC nos.)
8 2,4´ 17.5 I 1 5
18 2,2´,5 12.0 I 2 17,15
28 2,4,4´ 9.1 I 1 31
31 2,4´,5 10.6 I 1 28
44 2,2´,3,5´ 10.7 I 2
49 2,2´,4,5´ 12.1 I 2
52 2,2´,5,5´ 17.3 I 2
66 2,3´,4,4´ 11.0 I 1 95
70 2,3´,4´,5 13.9 II 1
74 2,4,4´,5 9.7 II 1
77 3,3´,4,4´ 10.3 III 0 110
81 3,4,4´,5 10.6 III 0
92 2,2´,3,5,5´ 10.6 I 2
95 2,2´,3´,5,6 11.4 II 3 66
99 2,2´,4,4´,5 9.7 I 2
101 2,2´,4,5,5´ 18.5 I 2 90
105 2,3,3´,4,4´ 11.0 III 1 153,132
110 2,3,3´,4´,6 11.1 II 2 77
118 2,3´,4,4´,5 17.0 II/III 1 123,149
123 2´,3,4,4´,5 11.8 III 1 149,118
126 3,3´,4,4´,5 11.0 III 0 129,178
128 2,2´,3,3´,4,4´ 14.2 II 2
129 2,2´,3,3´,4,5 9.7 I 2 126,178
132 2,2´,3,3´,4,6´ 11.1 II 3 105,153
137 2,2´,3,4,4´,5 12.0 II 2 176
138 2,2´,3,4,4´,5´ 27.6 II 2 158,160
141 2,2´,3,4,5,5´ 9.6 I 2 179
149 2,2´,3,4´,5´,6 12.1 I 3 123,118
153 2,2´,4,4´,5,5´ 16.7 II 2 105,132
156 2,3,3´,4,4´,5 9.4 III 1 171,202
157 2,3,3´,4,4´,5´ 4.3 III 1 173,201
169 3,3´,4,4´,5,5´ 9.2 III 0
170 2,2´,3,3´,4,4´,5 13.4 III 2 190
174 2,2´,3,3´,4,5,6´ 9.4 II 3
177 2,2´,3,3´,4´,5,6 9.5 II 3
178 2,2´,3,3´,5,5´,6 9.8 II 3 129,126
179 2,2´,3,3´,4,6,6´ 9.3 II 4 141
180 2,2´,3,4,4´,5,5´ 32.6 II 2
183 2,2´,3,4,4´,5´,6 10.3 I 3
187 2,2´,3,4´,5,5´,6 16.1 I 3
189 2,3,3´,4,4´,5,5´ 3.4 III 1
190 2,3,3´,4,4´,5,6 10.4 III 2 170
191 2,3,3´,4,4´,5´,6 2.6 III 2
194 2,3,3´,4,4´,5,5´,6 12.6 III 2
199 2,2´,3,3´,4,5,6,6´ 9.3 II 4
202 2,2´,3,3´,5,5´,6,6´ 10.6 I 4 156,171
PYE column HPLC separation of these congeners is shown in the column “Fraction.” Fraction I, 3.5–5.0 mL; fraction II,
5.0–7.5 mL; fraction III, 7.5–16 mL hexane. Articles • Differential neurochemical effects of Aroclor 1254
was monitored using a HRMDGC-ECD.
We determined the remaining PCB con-
geners applying our routine procedure to
environmental samples. Using the specially
prepared technical standard, we determined
the presence of every PCB congener. When
a congener was present at levels < 0.05%,
we considered it undetectable. Heart-cuts
were made for those congeners that coeluted
usually (27).
Analysis of PCDFs, PCDDs, and PCNs
in two lots of Aroclor 1254. We performed
the polychlorinated dibenzo-p-dioxin
(PCDD), polychlorinated dibenzofuran
(PCDF), and polychlorinated naphthalene
(PCN) analyses as per the modiﬁed methods
described previously (28,29). Isomer-speciﬁc
analyses were done using HRGC (HP6890)
low-resolution mass spectroscopy (Hewlett-
Packard 5973MS; Hewlett Packard, Tokyo,
Japan). 
PCB samples (50–100 mg of Aroclor
1254 with lot numbers 6024 and 124-191)
dissolved in 1–5 mL hexane were chro-
matographed on basic alumina (300 mesh,
5 g; Merck. Ltd., Darmstadt, Germany)
activated overnight at 130oC. After the ini-
tial absorption, 150 mL of hexane was
passed through the column to remove most
of the PCBs, followed by 100 mL of
dichloromethane:hexane (1:1) at 1 drop/sec
flow rate. The second fraction was concen-
trated to 1 mL and applied to activated char-
coal/silica gel minicolumn. The minicolumn
was washed with 40 mL toluene in the
reverse direction, and 30 mL 5% methylene
chloride/hexane, followed by 10 mL hexane
in the normal direction, before use. After the
initial absorption, the column was washed
with 10 mL of hexane and then 30 mL of
5% methylene chloride/hexane to remove
nonplanar PCBs. The final eluate that was
obtained using 40 mL of toluene in the
reverse direction was microconcentrated to
0.1 mL and applied for determination by
HRGC-LRMS. We used an HP6890 (gas
chromatograph)–HP5973 (mass spectrome-
ter) (Hewlett Packard) equipped with
SP-2331 fused silica capillary column (60
µm internal diameter) to analyze tetra- to
hexachlorinated PCDD/PCDFs, and a DB-
5 column (30 µm internal diameter) to
determine hepta- and octachlorinated iso-
mers. The MS was equipped with a quadra-
pole system and with an electron impact
ionization source.
The identification of PCDFs and
PCDDs was based on the fact that signals
were observed at characteristic mass numbers
(m/z) at proper retention times and in
proper ratio of the M+ and (M+2) cluster
ions in mass fragmentography. We identiﬁed
PCDF isomers with reference to authentic
standards from Wellington Laboratories Ltd.
(Ontario City, Ontario, Canada). We used
EPA-1613PAR for the 2,3,7,8-substituted
isomers, and we identiﬁed all the other iso-
mers reported according to Ryan et al. (30).
We used EPA-1613LCS and EPA-1613CSS
as an internal standard and a syringe spiking
standard. Recoveries of tetra-CDD, penta-
CDD, hexa-CDD, hepta-CDD and octa-
CDD congeners through the analytic
procedures were 66–140%, 83–129%,
70–112%, 62–121%, and 41–95%, respec-
tively. Recoveries of PCN congeners have
been reported earlier (31). PCN congener
1,2,3,4-tetra-CN was present in blank at trace
amounts and therefore was not quantiﬁed.
Neurochemical end points. Fractionation
of adult rat cerebella to obtain microsomes
and mitochondria was performed according to
Cotman and Matthews (32). We determined
intracellular Ca2+ buffering by measuring the
uptake of 45Ca2+ by microsomes and mito-
chondria as outlined by Moore et al. (33).
We isolated granule cells from cerebel-
lum of 7-day-old rats by the enzymatic dis-
ruption of cells as outlined by Gallo et al.
(34) with modifications (35). These cells
were maintained for 7 days in vitro in cul-
ture and used for protein kinase C (PKC)
translocation studies. We determined PKC
translocation by measuring 3H-phorbol ester
binding according to Vaccarino et al. (36).
Statistics. We analyzed the neurochemi-
cal data by two-way analysis of variance
(ANOVA) with lot number as one factor
and the concentration as the other followed
by Dunnett’s post-hoc test. All analyses were
performed with PROC GLM of SAS soft-
ware (37). We calculated the IC50 (concen-
tration that inhibits control activity by 50%)
and E50 (concentration that increases control
activity by 50%) values for 45Ca2+ uptake
and 3H-phorbol ester binding, respectively,
from the regression line ﬁt to the linear por-
tion of the curve using GraphPad Instat
Software (GraphPad Instat Software Inc.,
San Diego, CA, USA). We compared the
IC50 and E50 values between the two lots
using Student’s t-test. The accepted level of
signiﬁcance was set at p < 0.05. 
Results
Composition of PCB congeners and contami-
nants such as PCDFs, PCDD, and PCNs in
two lots of Aroclor 1254. A deﬁnitive statisti-
cal analysis of the quantitative performance
of this congener-specific analysis requires
detailed regression analysis of all standards,
analysis of multiple replicates of sample, and
multiple replicate injections. Time con-
straints, cumbersome heart-cut analysis of
non-ortho PCB congeners, and tedious analy-
ses of contaminants precluded such analyses.
The quantitative information provided in
this article permits only a comparison of
relative congener distribution in the two lots
of Aroclor 1254. 
The congener-speciﬁc analysis of Aroclor
1254 indicated that the composition of
PCBs was different in both lots (Table 2).
Some PCB congeners were higher in lot
6024, whereas some other congeners were
higher in lot 124-191. PCBs 40, 47–48, 70,
74, 77, 81, 92, 99, 105, 110, 123, 126, 138,
156, and 157 were higher in lot 6024. On
the other hand, PCBs 44, 49, 52, 66, 85, 97,
132, 135, (137+176), 149, 174, and 187
were higher in lot 124-191. 
When PCB congeners were grouped
based on the number of chlorines (mono- to
nona-; Table 5), both lots had similar per-
centages of PCB congeners except the hepta-
chlorinated ones, where lot 124-191 had
higher levels (5.9%) than did lot 6024
(3.5%). When the congeners were grouped
based on the number of ortho-chlorine sub-
stitutions, non-ortho PCBs were several-fold
(about 150-fold) higher in lot 6024 than in
lot 124-191. Mono-ortho PCBs were also
significantly higher in lot 6024 (38% of
total) than in lot 124-191 (24% of total).
On the other hand, tri-ortho PCBs were sig-
nificantly higher in lot 124-191 (21% of
total) than in lot 6024 (14% of total), while
di- and tetra-ortho PCBs were almost similar
in both lots (Table 6). 
PCDF composition was different in both
lots of Aroclor 1254 as well. Lot 6024 had
higher levels of total PCDFs as well as
2,3,7,8-PCDFs than did lot 124-191
(Tables 3 and 5). Based on the amount, total
as well as penta-CDFs to octa-CDFs were
higher in lot 6024 than in lot 124-191. The
percentage of tetra-CDFs was lower and
penta-CDFs was higher in lot 6024 than in
lot 124-191. Dioxins were not detected in
either lot of Aroclor 1254 (Tables 3 and 5).
Total PCNs were similar in both lots: 171
pg/µg in lot 6024 versus 155 pg/µg in lot
124-191. However, penta- and hexa-PCNs
were slightly higher in lot 6024, while hepta-
and octa-PCNs were slightly higher in lot
124-191 (Table 4). 
We calculated the TEQ values for both
lots of Aroclor 1254 using the toxic equivalent
factor (TEF) values from the World Health
Organization (38). We calculated the total
TEQ value for lot 124-191 as 39.42 µg/g, and
the TEQ value for lot 6024 was 400.63 µg/g.
The TEQ value for lot 6024 was 11 times
higher than that of lot 124-191 (39).
Neurochemical effects of two lots of
Aroclor 1254. Both lots of Aroclor 1254
inhibited microsomal 45Ca2+ uptake in a
concentration-dependent manner (Figure
1). Microsomal 45Ca2+ uptake in control
tissue is 50.5 ± 2.1 (mean ± SE) pmol/mg
protein/min. The ANOVA indicated a 
signiﬁcant interaction: The PCB levels were
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per milliliter; F5,36 = 8.41; p < 0.0001) or as
TEQ (picograms per milliliter; F2,30 =
52.05; p < 0.0001), suggesting that the
response of two lots of Aroclor 1254 on
microsomal 45Ca2+ uptake is different in
each case. The calculated IC50 values for
microsomal 45Ca2+ uptake were signiﬁcantly
different between two lots of Aroclor 1254;
the difference was much greater when the
values were transformed to represent TEQ
(nanograms TEQ per milliliter) compared to
the original concentrations (micrograms
Aroclor 1254 per milliliter).
Both lots of Aroclor 1254 also inhibited
mitochondrial 45Ca2+ uptake in a concen-
tration-dependent manner (Figure 2).
Mitochondrial 45Ca2+ uptake in control tis-
sue was 11.2 ± 0.4 (mean ± SE) pmol/mg
protein/min. The ANOVA indicated a sig-
nificant interaction. Either the PCB levels
were plotted as concentration (micrograms
per milliliter; F5,36 = 4.04; p < 0.0052) or as
TEQ (picograms per milliliter; F2,30 = 46.3;
p < 0.0001), suggesting that the response of
two lots of Aroclor 1254 on mitochondrial
45Ca2+ uptake is different in each case. The
IC50 values for mitochondrial 45Ca2+ uptake
were not significantly different among the
two lots of Aroclor 1254 when the levels
were represented as concentration (micro-
grams per milliliter); however, they are sig-
nificantly different when the values were
transformed to represent TEQ (Table 7).
Glutamate (30 µM), which was used as a
positive control, increased 3H-PDBu binding
by 2-fold, and this is in agreement with pre-
vious reports (40,41). Both lots of Aroclor
1254 signiﬁcantly increased 3H-PDBu bind-
ing in a concentration-dependent manner
(Figure 3). 3H-PDBu binding in control
cultures is 479 ± 25 (mean ± SE) fmol/mg
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Table 2. Congener-speciﬁc analysis of Aroclor 1254 with two different lot numbers (mg/g). 
PCBs IUPAC no. No. of Cl  o-Cl Lot 124-191 Lot 6024 PCBs IUPAC no. No. of Cl  o-Cl Lot 124-191 Lot 6024
21 1 1 – –
32 1 0 – –
43 1 0 – –
2,2´ 4 2 2 – –
2,3 5 2 1 – –
2,3´ 6 2 1 – –
2,4 7 2 1 – –
2,4´ 8 2 1 – –
2,5 9 2 1 – –
2,6 10 2 2 – –
3,3´ 11 2 0 – –
3,4 12 2 0 – –
3,4´ 13 2 0 – –
3,5 14 2 0 – –
4,4´ 15 2 0 – –
2,2´,3 16 3 2 – –
2,2´,4 17 3 2 – –
2,2´,5 18 3 2 – –
2,2´,6 19 3 3 – –
2,3,3´ 20 3 1 – –
2,3,4 21 3 1 – –
2,3,4´ 22 3 1 – –
2,3,5 23 3 1 – –
2,3,6 24 3 2 – –
2,3´,4 25 3 1 – –
2,3´,5 26 3 1 – –
2,3´,6 27 3 2 – –
2,4,4´ 28 3 1 – –
2,4,5 29 3 1 – –
2,4,6 30 3 2 – –
2,4´,5 31 3 1 – –
2,4´,6 32 3 2 – –
2´,3,4 33 3 1 – –
2´,3,5 34 3 1 – –
3,3´,4 35 3 0 – –
3,3´,5 36 3 0 – –
3,4,4´ 37 3 0 – –
3,4,5 38 3 0 – –
3,4´,5 39 3 0 – –
2,2´,3,3´ 40 4 2 2.11 3.36
2,2´,3,4 {41 + 4 2 9.71 9.81
2,3,4´,6 64} 4 2
2,2´,3,4´ 42 4 2 – –
2,2´,3,5 43 4 2 – –
2,2´,3,5´ 44 4 2 25.18 10.46
2,2´,3,6 45 4 3 – –
2,2´,3,6´ 46 4 3 – –
2,2´,4,4´ {47 + 4 2  – 5.96
2,2´,4,5 48} 4 2
2,2´,4,5´ 49 4 2 21.36 4.07
2,2´,4,6 50 4 3 – –
2,2´,4,6´ 51 4 3 – –
2,2´,5,5´ 52 4 2 35.06 7.73
2,2´,5,6´ 53 4 3 – –
2,2´,6,6´ 54 4 4 – –
2,3,3´,4 55 4 1 – –
2,3,3´,4´ 56 4 1 – –
2,3,3´,5 57 4 1 – –
2,3,3´,5´ 58 4 1 – –
2,3,3´,6 59 4 2 – –
2,3,4,4´ 60 4 1 – –
2,3,4,5 61 4 1 – –
2,3,4,6 62 4 2 – –
2,3,4´,5 63 4 1 – –
2,3,5,6 65 4 2 – –
2,3´,4,4´ {66 + 4 1  90.78 75.98
2,2´,3,5´,6 95} 5 3
2,3´,4,5 67 4 1 – –
2,3´,4,5´ 68 4 1 – –
2,3´,4,6 69 4 2 – –
2,3´,4´,5 70 4 1 25.24 63.57
2,3´,4´,6 71 4 2 – –
2,3´,5,5´ 72 4 1 – –
2,3´,5´,6 73 4 2 – –
2,4,4´,5 74 4 1 4.36 23.47
2,4,4´,6 75 4 2 – –
2´,3,4,5 76 4 1 – –
3,3´,4,4´ 77 4 0 0.01 27.20
3,3´,4,5 78 4 0 – –
3,3´,4,5´ 79 4 0 – –
3,3´,5,5´ 80 4 0 – –
3,4,4´,5 81 4 0 0.01 0.28
2,2´,3,3´,4 {82 + 5 2  22.02 20.98
2,2´,3,5,5´,6 151} 6 3
2,2´,3,3´,5 83 5 2 4.29 4.30
2,2´,3,3´,6 84 5 3 – –
2,2´,3,4,4´ 85 5 2 7.16 –
2,2´,3,4,5 86 5 2 – –
2,2´,3,4,5´ {87 +  5 2 42.21 47.22
2,3,4,4´,6 115} 5 2
2,2´,3,4,6 88 5 3 – –
2,2´,3,4,6´ 89 5 3 – –
2,2´,3,4´,5 {90 + 5 2 72.28 61.60
2,2´,4,5,5´ 101} 5 2
2,2´,3,4´,6 91 5 3 20.24 22.54
2,2´,3,5,5´ 92 5 2 28.34 36.00
2,2´,3,5,6 93 5 3 – –
2,2´,3,5,6´ 94 5 3 – –
2,2´,3,6,6´ 96 5 4 – –
2,2´,3´,4,5 97 5 2 20.33 –
2,2´,3´,4,6 98 5 3 – –
2,2´,4,4´,5 99 5 2 24.97 37.10
2,3,3´,4,6 109 5 2 – –
2,2´,4,4´,6 100 5 3 – –
2,2´,4,5,6´ 102 5 3 – –
2,2´,4,5´,6 103 5 3 – –
2,2´,4,6,6´ 104 5 4 – –
continuedprotein/15 min. The ANOVA indicated a
signiﬁcant interaction: Either the PCB levels
were plotted as concentration (F4,49 = 5.94; p
< 0.0006) or as TEQ (F1,49 = 64.2; p <
0.0001), suggesting that the response of two
lots of Aroclor 1254 on 3H-PDBu binding is
different in each case. The E50 values for 3H-
PDBu binding were significantly different
between the two lots of Aroclor 1254; the
difference was much greater when the values
were transformed to represent TEQ than for
the original concentrations (Table 7).
In general, the data from neurochemical
end points indicate that the effects of two
lots of Aroclor 1254 on intracellular Ca2+
buffering is comparable, but lot 124-191
was more effective on PKC translocation
than was lot 6024. The potency difference
between the two lots ranged from 1.2- to
2.5-fold when PCB levels were represented
as concentration. However, this difference
increased to several-fold (8- to 29-fold)
when PCB levels were transformed to TEQs
(Figures 1–3; Table 7). 
Discussion
Health risks associated with exposure to
PCBs and related chemicals have been
assessed based on either total PCB concen-
trations or 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) TEQs using the TEF
concept when congener-specific data are
available. U.S. EPA has adopted the TEF
approach as an interim procedure that
assumes additivity for the toxic effects of
individual congeners in the mixtures and a
common mechanism of toxic action (e.g.,
ability to interact with and activate the aryl
hydrocarbon receptor). In addition, assess-
ment of risks to humans is based on the
reference doses (RfDs) derived from animal
studies with commercial PCB mixtures (15).
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Table 2 (continued).
PCBs IUPAC no. No. of Cl  No. of o-Cl Lot 124-191 Lot 6024 PCBs IUPAC no. No. of Cl  o-Cl Lot 124-191 Lot 6024
No. of Cl, number of total chlorine substitutions; No. of o-Cl, number of ortho-chlorine substitutions. PCBs without any values are below the detection limit, < 0.05% (w/w). The PCB num-
bers are in agreement with IUPAC convention, but note the change in numbers for PCBs 199, 200, and 201 compared to Ballschmitter and Zell (3).
2,3,3´,4,4´ 105 5 1 51.00 130.00
2,3,3´,4,5 106 5 1 – –
2,3,3´,4´,5 107 5 1 – –
2,3,3´,4,5´ 108 5 1 – –
2,3,3´,4´,6 110 5 2 76.57 87.15
2,3,3´,5,5´ 111 5 1 – –
2,3,3´,5,6 112 5 2 – –
2,3,3´,5´,6 113 5 2 – –
2,3,4,4´,5 {114 + 5 1  0.05 0.78
2´,3,3´,4,5 122 +  5 1
2,2´,3,3´,4,6 131} 6 3
2,3,4,5,6 116 5 2 – –
2,3,4´,5,6 117 5 2 – –
2,3´,4,4´,5 118 5 1 127.00 124.00
2,3´,4,4´,6 119 5 2 – –
2,3´,4,5,5´ 120 5 1 – –
2,3´,4,5´,6 121 5 2 – –
2´,3,4,4´,5 123 5 1 0.57 2.14
2´,3,4,5,5´ 124 5 1 – –
2´,3,4,5,6´ 125 5 2 – –
3,3´,4,4´,5 126 5 0 0.17 3.24
3,3´,4,5,5´ 127 5 0 – –
2,2´,3,3´,4,4´ 128 6 2 7.04 9.67
2,2´,3,3´,4,5 129 6 2 8.70 9.34
2,2´,3,3´,4,5´ 130 6 2 – –
2,2´,3,3´,4,6´ 132 6 3 33.03 25.82
2,2´,3,3´,5,5´ 133 6 2 – –
2,2´,3,3´,5,6 134 6 3 – –
2,2´,3,3´,5,6´ 135 6 3 12.30 6.69
2,2´,3,3´,6,6´ 136 6 4 – –
2,2´,3,4,4´,5 {137 + 6 2 4.18 –
2,2´,3,3´,4,6,6´ 176} 7 4
2,2´,3,4,4´,5´ 138 6 2 58.70 71.80
2,2´,3,4,4´,6 139 6 3 – –
2,2´,3,4,4´,6´ 140 6 3 – –
2,2´,3,4,5,5´ {141 + 6 2 12.18 12.86
2,2´,3,3´,5,6,6´ 179} 7 4
2,2´,3,4,5,6 142 6 3 – –
2,2´,3,4,5,6´ 143 6 3 – –
2,2´,3,4,5´,6 144 6 3 – –
2,2´,3,4,6,6´ 145 6 4 – –
2,2´,3,4´,5,5´ 146 6 2 10.29 8.44
2,2´,3,4´,5,6 147 6 3 – –
2,2´,3,4´,5,6´ 148 6 3 – –
2,2´,3,4´,5´,6 149 6 3 41.76 14.37
2,2´,3,4´,6,6´ 150 6 4 – –
2,2´,3,5,6,6´ 152 6 4 – –
2,2´,4,4´,5,5´ 153 6 2 31.80 33.93
2,2´,4,4´,5,6´ 154 6 3 – –
2,2´,4,4´,6,6´ 155 6 4 – –
2,3,3´,4,4´,5 156 6 1 4.80 51.00
2,3,3´,4,4´,5´ 157 6 1 0.36 26.30
2,3,3´,4,4´,6 158 6 2 – –
2,3,3´,4,5,5´ 159 6 1 – –
2,3,3´,4,5,6 160 6 2 – –
2,3,3´,4,5´,6 161 6 2 – –
2,3,3´,4´,5,5´ 162 6 1 – –
2,3,3´,4´,5,6 163 6 2 – –
2,3,3´,4´,5´,6 164 6 2 – –
2,3,3´,5,5´,6 165 6 2 – –
2,3,4,4´,5,6 166 6 2 – –
2,3´,4,4´,5,5´ 167 6 1 – –
2,3´,4,4´,5´,6 168 6 2 – –
3,3´,4,4´,5,5´ 169 6 0 0.01 0.02
2,2´,3,3´,4,4´,5 170 7 2 4.02 3.39
2,2´,3,3´,4,4´,6 171 7 3 – –
2,2´,3,3´,4,5,5´ 172 7 2 – –
2,2´,3,3´,4,5,6 173 7 3 0.77 1.74
2,2´,3,3´,4,5,6´ 174 7 3 31.12 18.32
2,2´,3,3´,4,5´,6 175 7 3 – –
2,2´,3,3´,4´,5,6 177 7 3 1.59 0.88
2,2´,3,3´,5,5´,6 178 7 3 – –
2,2´,3,4,4´,5,5´ 180 7 2 5.18 4.51
2,2´,3,4,4´,5,6 181 7 3 – –
2,2´,3,4,4´,5,6´ 182 7 3 – –
2,2´,3,4,4´,5´,6 183 7 3 1.97 1.36
2,2´,3,4,4´,6,6´ 184 7 4 – –
2,2´,3,4,5,5´,6 185 7 3 – –
2,2´,3,4,5,6,6´ 186 7 4 – –
2,2´,3,4´,5,5´,6 187  7 3 3.51 0.39
2,2´,3,4´,5,6,6´ 188 7 4 – –
2,3,3´,4,4´,5,5´ 189 7 1 – –
2,3,3´,4,4´,5,6 190 7 2 – –
2,3,3´,4,4´,5´,6 191 7 2 – –
2,3,3´,4,5,5´,6 192 7 2 – –
2,3,3´,4´,5,5´,6 193 7 2 – –
2,2´,3,3´,4,4´,5,5´ 194 8 2 – –
2,2´,3,3´,4,4´,5,6 195 8 3 – –
2,2´,3,3´,4,4´,5´,6 196 8 3 – –
2,2´,3,3´,4,4´,6,6´ 197 8 4 – –
2,2´,3,3´,4,5,5´,6 198 8 3 – –
2,2´,3,3´,4,5,6,6´ 199 8 4 – –
2,2´,3,3´,4,5´,6,6´ 200 8 4 – –
2,2´,3,3´,4,5,5´,6´ 201 8 3 – –
2,2´,3,3´,5,5´,6,6´ 202 8 4 – –
2,2´,3,4,4´,5,5´,6 203 8 3 – –
2,2´,3,4,4´,5,6,6´ 204 8 4 – –
2,3,3´,4,4´,5,5´,6 205 8 2 – –
2,2´,3,3´,4,4´,5,5´,6 206 9 3 – –
2,2´,3,3´,4,4´,5,6,6´ 207 9 4 – –
2,2´,3,3´,4,5,5´,6,6´ 208 9 4 – –
2,2´,3,3´,4,4´,5,5´,6,6´ 209 10 4 – –Recently, a new approach has been devel-
oped to assess the cancer risk from environ-
mental PCB exposure, and this approach
considers both toxicity and environmental
processes to distinguish among environmen-
tal mixtures (42). Although current
risk/exposure assessment is based on these
approaches, several problems were identiﬁed
with the recent literature. Several studies
from our laboratory as well as others indicate
that ortho-substituted PCBs that do not or
weakly bind to aryl hydrocarbon receptors
are highly active in neuronal and other
preparations (43–45). Because ortho-PCBs
are highly abundant in environmental sam-
ples (> 99%), lack of significant considera-
tion of this group of PCBs in the TEF
approach could lead to underestimation of
risk associated with exposure to these PCBs.
Likewise, RfDs derived from commercial
mixtures might not be accurate because the
pattern of relative proportions of PCBs in
environmental mixtures is variable and does
not resemble the composition of the original
PCB mixtures that were released into the
environment. Recent reports indicate sub-
stantial differences in the congener composi-
tion among Aroclor lots (17,18), so their
biologic effects could be different (19,20). In
the present study, we report a thorough PCB
congener analysis along with the contami-
nants such as PCDFs, PCNs, and any diox-
ins in two different lots of Aroclor 1254
mixtures and their effects on selected neuro-
chemical end points that were previously
reported to be sensitive to PCBs in neuronal
preparations (21–23).
Results from this study indicate that the
composition of PCB congeners was signifi-
cantly different between the two lot numbers
of Aroclor 1254. We detected no dioxins in
either lot (< 2 ppb), as anticipated. PCNs
were similar in both lots. Other contami-
nants in this mixture, such as PCDFs, were
detectable, mainly because PCDFs are pro-
duced often as co-contaminants in PCB
preparation (28). In the present study, lot-
to-lot differences in PCDF levels have been
identified, with lot 6024 having 3.4 times
more PCDFs than lot 124-191. Differences
in the congener composition between differ-
ent lots for a variety of Aroclor mixtures
have been previously reported (17,18).
However, this is the first detailed report of
congener-speciﬁc analysis that includes cont-
aminants in these two lots of Aroclor 1254, a
widely used commercial mixture in the
United States for conducting scientific
research. Of the two lots of Aroclor 1254
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Table 4. Concentration (ng/g; ppb) of PCNs in
Aroclor 1254 with two different lot numbers.
PCNs Lot 124–191 Lot 6024
3 Chlorines
135 0.9 4.7
136 0.0 0.0
146/124 6.2 33.8
137 0.6 2.0
125 0.8 3.5
126 0.7 3.4
167/127 1.2 4.8
123 0.2 0.4
236 0.2 0.7
145/138 3.0 12.9
128 1.3 3.6
4 Chlorines
1357 6.7 17.0
1246/1247/1257 56.9 120.2
1467 33.0 53.4
1367 1.0 2.3
1235/1256 12.1 21.9
1368/1358 16.8 55.8
1234/1236 1.3 2.7
1245/1237 12.8 14.4
1267 5.2 13.1
1248 19.2 43.1
1258 71.6 150.5
2367 0.0 0.0
1268 1.5 5.8
1458 36.2 46.3
1238 0.0 0.0
1278 44.1 15.2
5 Chlorines
12357/12467 5709.1 2591.8
12457 423.0 105.8
12468 3005.4 735.0
12346 397.5 140.6
12356 761.8 227.5
12456 3183.9 1250.3
12367 59.7 8.4
12478 5586.3 1243.1
12358 2183.1 737.8
12368 0.0 0.0
12458 1550.3 880.3
12345 276.7 106.3
12378 122.9 89.6
6 Chlorines
123467/123567 8899.8 6233.4
123457/123568 15260.7 10030.7
123578 31115.2 18089.3
124568/124578 24761.0 21068.5
123456 10914.4 6512.7
123458 3992.7 3736.1
123678 45.0 40.1
7 Chlorines
1234567 18527.3 27277.7
1234568 26320.4 38534.3
8 Chlorines
12345678 7799.1 14988.0
Table 3. Concentration (ng/g; ppb) of PCDFs and PCDDs in Aroclor 1254 with two different lot numbers.
PCDFs/PCDDs Lot 124–191 Lot 6024 PCDFs/PCDDs Lot 124–191 Lot 6024T
Tetra-CDF (0.0 = ND; < 2.0 ppb)
1368 – –
1378/1379 10.0 –
1347 – –
1468 – –
1247/1367 – –
1348 – –
1346/1248 109.9 7.6
1246/1268 25.0 –
1478/1369/1237 15.0 –
1678/1234 – –
2468/1238/1467/1236 54.9 –
1349 – –
1278 79.9 –
1267/1279 30.0 30.4
1469 – –
1249 84.9 68.5
2368 – –
2467 15.0 15.2
1239 – –
2347 89.9 289.2
1269 – –
2378 129.9 350.1
2348 719.2 730.6
2346 49.9 49.5
2367 219.7 152.2
3467 – –
1289 44.9 –
Penta-CDF (0.0 = ND; < 2.0 ppb)
13468 – –
12468 – –
13678 – –
13479 – –
12368/13478 8.6 20.9
12478 235.2 292.2
12479/13467 4.3 20.9
12467 94.1 41.7
14678/12347 102.6 41.7
13469 – –
Penta-CDF (0.0 = ND; < 2.0 ppb)
12348/12378 295.0 1920.2
12346 34.2 –
12379 – –
12367 8.6 167.0
12469/12678 615.7 2838.6
12679 – –
12369 – –
23468 81.2 250.5
12349 – –
12489 470.3 3757.0
23478 821.0 4049.2
12389 – –
23467 162.5 751.4
Hexa-CDF (0.0 = ND; < 4.0 ppb)
123468 17.1 –
134678 85.3 –
134679 – –
124678 238.9 –
124679 17.1 –
123478/123479 1638.1 4571.4
123678 733.7 3190.5
124689 418.1 952.4
123467 341.3 2142.9
123679 – –
123469/123689 597.2 2238.1
123789 – –
123489 443.7 2761.9
234678 213.3 1333.3
Hepta-CDF (0.0 = ND; < 4.0 ppb)
1234678 581.8 1506.5
1234679 375.8 1286.8
1234689 157.6 470.8
1234789 533.3 1459.4
Octa-CDF (0.0 = ND; < 4.0 ppb)
12346789 356.0 945.6
PCDDs ND ND
< 2.0 ppb < 2.0 ppb
ND, not detected.tested, lot 6024 has more non-ortho PCBs
and PCDFs contributing to higher TEQ val-
ues. Recently, Frame (18) discussed the man-
ufacturing process of several lots of Aroclor
1254 and the differences in the congener
composition. Lot 124-191 of Aroclor 1254
has the typical PCB congener distribution.
However, lot 6024 has unusually enhanced
levels of non-ortho and mono-ortho congeners
and PCDFs. Lot 6024 has been traced back
to Monsanto lot KI-6024 and represents the
late (1974–1976) production of Aroclor
1254s, which used a two-stage chlorination
procedure (18). In the first stage, biphenyl
was chlorinated to 42% chlorine content by
weight as for Aroclor 1242 production and
then fractionated to give a distillate that was
sold as Aroclor 1016. In the second stage, the
residue from the distillate was further chlori-
nated to 54% chlorine by weight, greatly
increasing the levels of non-ortho and mono-
ortho congeners with high TEF values (18).
Caution should be used when comparing the
results using this lot (lot 6024) with results
from other lots of Aroclor 1254.
The biologic activity of two lots of
Aroclor 1254 was tested on two previously
established neurochemical end points, intra-
cellular Ca2+ buffering and PKC transloca-
tion. We selected these two end points on
the basis of our previous work, where intra-
cellular Ca2+ buffering by endoplasmic retic-
ulum and mitochondria as well as PKC
translocation were preferentially affected by
ortho-substituted PCBs (43). Intracellular
Ca2+ buffering is essential for maintaining
normal calcium homeostasis (46). When
intracellular free-Ca2+ levels increase, PKC
may translocate from cytosol to the mem-
brane, where it gets activated. Increases in
intracellular free Ca2+ levels by PCBs have
been reported by several investigators in sev-
eral cell systems (35,47,48). In addition,
increases in intracellular free-Ca2+ levels,
inhibition of Ca2+ buffering, and PKC acti-
vation and translocation have been involved
in the neurotoxicity of a variety of environ-
mental chemicals (49–51). When these two
lots of Aroclors were tested on Ca2+ buffer-
ing and PKC translocation in brain prepara-
tions, the effects were signiﬁcantly different.
Intracellular Ca2+ buffering by microsomes
and mitochondria was signiﬁcantly inhibited
by both lots of Aroclor 1254 in a concentra-
tion-dependent manner. Lot 6024 seems to
be more potent than lot 124-191. This dif-
ference in the potency increased several-fold
when the concentration of Aroclor 1254 was
transformed to TEQ values (derived from
dioxin TEFs), demonstrating that the greater
effect with lot 6024 is not caused by the
greater aryl hydrocarbon-receptor binding
activity alone. PKC translocation, measured
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Figure 1. Inhibition of rat brain microsomal 45Ca2+ uptake by Aroclor 1254 with two lot numbers. The 45Ca2+
uptake was represented as percent of control (50.5 ± 2.1 pmol/mg protein/min). Values are mean ± SEM of
four preparations, assayed in triplicate.
Figure 2. Inhibition of rat brain mitochondrial 45Ca2+ uptake by Aroclor 1254 with two lot numbers. The
45Ca2+ uptake was represented as percent of control (11.2 ± 0.4 pmol/mg protein/min). Values are mean ±
SEM of four preparations, assayed in triplicate. 
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Table 5. Different PCB/PCDF/PCDD/PCN congeners based on the number of chlorines in the Aroclor 1254
mixtures with two different lot numbers.
Concentration 
Aroclor 1254  Mono, di, Octa,
lot numbers Units and tri  Tetra Penta Hexa Hepta nona
124-191
PCBs ng/µg ND 168 (17.6) 504 (52.7) 228 (23.8) 56 (5.9) ND
PCDFs pg/µg ND 1.68 (14.3) 2.93 (25.8) 4.74 (41.8) 1.65 (14.5) 0.36 (3.1)
2,3,7,8-PCDFs pg/µg ND 0.13 (2.6) 1.12 (22.6) 2.58 (52.3) 1.12 (22.5) ND
PCDDs pg/µg ND ND ND ND ND ND
PCNs pg/µg 0.070 0.562 8.12 65.71 65.81 14.99
6024
PCBs ng/µg ND 194 (18.6) 539 (51.6) 274 (26.3) 37 (3.5) ND
PCDFs pg/µg ND 1.69 (4.4) 14.15 (36.6) 17.19 (44.4) 4.72 (12.2) 0.95 (2.4)
2,3,7,8-PCDFs pg/µg ND 0.35 (1.9) 5.97 (32.5) 9.09 (49.5) 2.97 (16.1) ND
PCDDs pg/µg ND ND ND ND ND ND
PCNs pg/µg 0.015 0.319 23.26 94.99 44.85 7.80
ND, not detected. The numbers in parentheses indicate the percentage of total with respective groups (PCBs, PCDFs,
2378 PCDFs, or PCDDs). 
Table 6. PCB congeners (pg/ng) based on ortho-
substitutions in the Aroclor 1254 mixtures with
two different lot numbers.
Total PCB congeners (pg/ng)
PCBs Lot 124-191 Lot 6024 
Non-ortho 0.2 30.74
(0.02%) (2.9%)
Mono-ortho 230.8 393.4
(24.1%) (37.7%)
Di-ortho 514.5 472.8
(53.8%) (45.3%)
Tri-ortho 202.7 140.6
(21.2%) (13.5%)
Tetra-ortho 8.18 6.43
(0.85%) (0.62%)
The numbers in parentheses indicate the percentage of
total.as 3H-phorbol ester binding, was signiﬁcantly
increased by both lots of Aroclor 1254; lot
124-191 was significantly more active than
lot 6024. As seen with Ca2+ buffering, the
difference in the potency also increased sev-
eral-fold when the concentration of Aroclor
1254 was transformed to TEQ, suggesting
that the dioxin-like congeners are not
responsible for this effect. The differential
effects of two lots of Aroclor 1254 on the
selected neurochemical end points could not
be clearly explained by the differences in their
TEQ values. However, Burgin et al. (39)
reported that TEQ predicted the effects on
ethoxyresorufin-O-deethylase (EROD) or
methoxyresorufin-O-deethylase (MROD)
activities (strict dioxin-like effects), but not
pentoxyresorufin-O-deethylase (PROD) or
circulating serum thyroxine levels. These
results suggest that different end points may
be observed with different PCB mixtures.
Hence, a mixture that is of low concern for
one end point may be of greater concern for
another end point. In addition, these results
suggest that overall toxicity of complex mix-
tures can not be entirely predicted based on
the TEQ values and caution should be used
when making risk assessment decisions
about chemical mixtures that involve both
aryl hydrocarbon receptor-dependent and
-independent mechanisms.
In general, current data indicate that the
effects of two lots of Aroclor 1254 on
selected neurochemical end points could not
be explained either by total mass or by TEQ.
These effects could not be attributed to the
differences in the percentage of non-ortho
congeners or dibenzofurans because they
were inactive on these two parameters. These
effects also could not be attributed to the
interactions among the congeners and conta-
minants because our previous studies indi-
cated that inactive congeners did not
interfere with the activity of active con-
geners, and the interactions between two
active congeners seem to follow additivity
(52). However, these differential effects
could be caused by differences in the compo-
sition of ortho-congeners in these two mix-
tures, because PCBs with ortho-lateral
substitutions have been shown to exhibit dif-
ferent activities on the selected neurochemi-
cal end points (43). Because of these
differential effects between different lots, the
composition of Aroclor mixtures used in
investigations should be disclosed.
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Figure 3. Increased 3H-phorbol ester (PDBu) binding in rat cerebellar granule cells by Aroclor 1254 with
two lot numbers. The 3H-PDBu binding was represented as percent of control (479 ± 25 fmol/mg protein/15
min). Values are mean ± SEM of six preparations, assayed in triplicate. 
Table 7. Differential effects of two lots of Aroclor 1254 on intracellular Ca2+ buffering and PKC transloca-
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PKC translocation (E50) 11.03 ± 1.29 28.01 ± 6.01*  0.435 ± 0.051 11.22 ± 2.41*
*Signiﬁcantly different from lot 124-191 at p < 0.05. Values are mean ± SE of 4–6 dose–response experiments shown in
Figures 1–3 (n = 4–6). IC50 values for Ca2+ buffering and E50 values for PKC translocation (3H-phorbol ester binding) were
calculated from the regression line ﬁt to the linear portion of the data presented in Figures 1–3.Articles • Differential neurochemical effects of Aroclor 1254
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